SCHEMBL4217318

SCHEMBL4217318

O=C(O)c1ccc(Oc2ccccc2)cc1Nc1cccc2cccnc12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.49
▸ PLEC Q15149 1/20 0.49
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MAPK8 P45983 1/20 0.47
▸ AKR1C3 P42330 3/20 0.47
▸ AKR1C2 P52895 3/20 0.47
▸ SLC40A1 Q9NP59 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ KDR P35968 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ ALOX12 P18054 1/20 0.45
▸ PYGL P06737 1/20 0.45
▸ PYGM P11217 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10505456 0.82 ALDH1A1 (0.60) MAPTPLECMEN1KMT2ALMNA
SCHEMBL4215643 0.82 MAPT (0.52) MAPTPLECMEN1KMT2ALMNA
SCHEMBL4211086 0.79 GLO1 (0.51) MAPTPLECMEN1KMT2ALMNA
SCHEMBL27716681 0.76 AKR1C3 (0.58) MEN1KMT2ALMNAAKR1C3AKR1C2
SCHEMBL4225339 0.76 AKR1C3 (0.73) MAPTAKR1C3AKR1C2CYP2C9CYP2C19
SCHEMBL5443633 0.74 KDR (0.60) MAPTPLECMEN1KMT2ALMNA
SCHEMBL2293819 0.72 KDR (0.59) MAPTMEN1KMT2AALDH1A1KDR
SCHEMBL29775266 0.72 HDAC3 (0.52) MAPTPLECMEN1KMT2ALMNA
SCHEMBL13337941 0.72 MEN1 (0.56) MAPTMEN1KMT2ALMNASLC40A1
SCHEMBL379216 0.71 GLO1 (0.59) MAPTMEN1KMT2ALMNASLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 — — US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 — — US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 — — US disclosed
EP-1860098-B1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-14 — — EP disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 — — US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 — — US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 — — US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 — — EP disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 MAPT 4791/4885PLEC 4389/4885MEN1 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback